SELLAS Life Sciences (SLS) Dividends Paid - Common (2018)
SELLAS Life Sciences' (SLS) quarterly Dividends Paid - Common came in at $376000.0 in Q3 2018.
SELLAS Life Sciences (SLS) Dividends Paid - Common (2018) Analysis & Trends
SELLAS Life Sciences (SLS) has 1 years of Dividends Paid - Common data on file, last reported at $376000.0 in Q3 2018.
- On a quarterly basis, Dividends Paid - Common changed N/A year-over-year to $376000.0 in Q3 2018; TTM through Dec 2019 was $376000.0, a 0.0% change from a year earlier, with the FY2018 full-year figure at $487000.0, changed N/A from the prior year.
- Dividends Paid - Common for Q3 2018 stood at $376000.0.
- Over the last five years, Dividends Paid - Common for SLS reached as high as $376000.0 in Q3 2018 and fell as low as $376000.0 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 97.80 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | SELLAS Life Sciences | 3.23 Mn | 3.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 376,000.00 |
| Sep 30, 2018 | 376,000.00 |